TY - JOUR T1 - A Practical Overview of Aromatase Inhibitors JF - Anticancer Research JO - Anticancer Res SP - 2497 LP - 2502 VL - 25 IS - 3C AU - JAWAID YOUNUS AU - THEODORE A. VANDENBERG Y1 - 2005/05/01 UR - http://ar.iiarjournals.org/content/25/3C/2497.abstract N2 - Tamoxifen has been the standard adjuvant therapy for patients with breast cancer for several decades. Various recently completed adjuvant trials using aromatase inhibitors have shown the superiority of these agents over Tamoxifen or placebo, when used in post-menopausal women. The results from these trials present a challenging situation for practicing oncologists with regards to the choice, duration, sequence of therapy, follow-up and side-effects of aromatase inhibitors. Various management issues from a practical angle for oncologists are discussed for the effective use of these agents, with an evidence-based approach. ER -